Technical / White Paper

Identifying the Product

Published

Format: PDF file | Document type: Technical / White Paper

Identifying the Product

With a generic cliff approaching, the 505(b)(2) development process can make changes to reference products for greater profit potential and lower risk. Camargo Pharmaceutical Services offers a clear process to identify products that have documented market differentiation:

  • Selection criteria
  • Identify, assess and rank unmet needs
  • Defend the value and maximize investment
  • Narrow to one candidate
  • The 505(b)(2) development plan
  • Product case history’s

For differentiated product benefits, embark on a 505(b)(2) with Camargo.

See us at the AAPS 2012 Annual Meeting, booth #4800.

Related resources from Camargo Pharmaceutical Services

Show more

Supplier info centre